Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2018
At a glance
- Drugs Glycopyrrolate (Primary) ; Neostigmine (Primary) ; Sugammadex (Primary) ; Remifentanil; Rocuronium bromide; Sevoflurane
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 14 Aug 2018 Planned primary completion date changed from 15 Apr 2018 to 15 Dec 2018.
- 09 May 2017 Status changed from not yet recruiting to recruiting.
- 17 Apr 2017 New trial record